MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,828 | -23.3% | 143,172 | +98.7% | 0.00% | -100.0% |
| Q2 2023 | $237,021 | +70.1% | 72,043 | +112.5% | 0.00% | – |
| Q1 2023 | $139,337 | -82.4% | 33,902 | -74.9% | 0.00% | -100.0% |
| Q4 2022 | $792,278 | +29.7% | 135,201 | +49.5% | 0.00% | +100.0% |
| Q3 2022 | $611,000 | +465.7% | 90,413 | +286.4% | 0.00% | – |
| Q2 2022 | $108,000 | +111.8% | 23,400 | +84.1% | 0.00% | – |
| Q1 2022 | $51,000 | -56.0% | 12,712 | +3.1% | 0.00% | – |
| Q3 2021 | $116,000 | -30.5% | 12,330 | 0.0% | 0.00% | – |
| Q2 2021 | $167,000 | -77.8% | 12,330 | -73.4% | 0.00% | -100.0% |
| Q1 2021 | $751,000 | -30.4% | 46,415 | +14.5% | 0.00% | -50.0% |
| Q4 2020 | $1,079,000 | +24.2% | 40,550 | -13.1% | 0.00% | +100.0% |
| Q3 2020 | $869,000 | -29.6% | 46,649 | -11.6% | 0.00% | -50.0% |
| Q2 2020 | $1,235,000 | +946.6% | 52,759 | +161.1% | 0.00% | – |
| Q1 2020 | $118,000 | – | 20,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |